# Study to Assess the Effects of Mipomersen on Lipid and Lipoprotein Metabolism in Healthy Subjects

> **NCT01414881** · PHASE1 · COMPLETED · sponsor: **Kastle Therapeutics, LLC** · enrollment: 20 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** mipomersen
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01414881
- **Lead sponsor:** Kastle Therapeutics, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2012-06
- **Final completion:** 2012-11
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2016-08-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01414881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01414881, "Study to Assess the Effects of Mipomersen on Lipid and Lipoprotein Metabolism in Healthy Subjects". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01414881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*